Idiopathic giant esophageal ulcers have been reported in transplant recipients, 1 however treatment options are limited primarily based upon the lack of successful therapies. There has been limited experience with using thalidomide in this population. We report our experience with using thalidomide
Successful treatment of cerebral tuberculosis in a liver transplant recipient
โ Scribed by Sonal Asthana; Glenn K. Bonney; Ashley Guthrie; Mervyn H. Davies; K. Rajendra Prasad
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 120 KB
- Volume
- 15
- Category
- Article
- ISSN
- 1527-6465
- DOI
- 10.1002/lt.21577
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Recurrent hepatitis C after liver transplantation is a universal phenomenon. Graft reinfection occurs rapidly; once it is established, allograft cirrhosis and decompensation rapidly ensue in many patients. Treatment with pegylated interferon plus ribavirin is the standard of care among nontransplant
A 42-year-old white man with morbid obesity and hypertriglyceridemia was noted to have nonalcoholic steatohepatitis (NASH) at the time of a laparoscopic cholecystectomy for presumed gallstone pancreatitis. His postoperative course was complicated by a 50-kg weight loss and continued right upper quad
A s liver transplantation in the alcoholic patient has become more common, the outcome in these patients has become important information in grounding the ethical debate that still surrounds this charged topic. Controversy has existed since alcoholic patients began receiving organ transplants in the
Mycobacterium tuberculosis (MTB) causes substantial morbidity and mortality in liver transplant recipients. We examined the efficacy of isoniazid latent Mycobacterium tuberculosis infection (LTBI) treatment in liver transplant recipients and reviewed systematically all cases of active MTB infection